InsidersTradesSigma
Follow the Aspira Pathlab share price and the full directors' dealings record of the company, a listed equity based in India. Shares trade on IN IN, under the supervision of SEBI (PIT + SAST). Market capitalisation: €1.3bn. The latest transaction was disclosed on 17 June 2026 (Acquisition). Among the most active insiders: Shraddha Bhanushali & PACs. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
5 of 5 declarations
Aspira Pathlab is a company specializing in medical diagnostic services, providing laboratory analysis and health testing. It operates in the XBOM market.